Β-actin does not show the characteristics of a reference protein in human cortex.


Journal

Electrophoresis
ISSN: 1522-2683
Titre abrégé: Electrophoresis
Pays: Germany
ID NLM: 8204476

Informations de publication

Date de publication:
01 2019
Historique:
received: 01 08 2018
revised: 24 09 2018
accepted: 15 10 2018
pubmed: 28 10 2018
medline: 31 12 2019
entrez: 28 10 2018
Statut: ppublish

Résumé

Levels of a reference protein must be the same as a proportion of total protein in all tissues and, in the study of human diseases, cannot vary with factors such as age, gender or disease pathophysiology. It is increasingly apparent that there may be few, if any, proteins that display the characteristics of a reference protein within the human central nervous system (CNS). To begin to challenge this hypothesis, we used Western blotting to compare variance in levels of the "gold standard" reference protein, β-actin, in Brodmann's area 9 from 194 subjects to variance of total transferred protein measured as intensity of Ponceau S staining. The coefficient of variance of sum intensity measurements for β-actin levels across all donors was 47% compared to 24 and 27% for the sum intensity of Ponceau S staining measured using two different detection techniques. These data strongly suggest that the level of β-actin, proportional to total protein, is not constant in human cortex which raises further doubt about the use of reference proteins to normalise data in human CNS studies. Considering our data, we suggest an alternative approach to presenting data from Western blotting of human CNS.

Identifiants

pubmed: 30367480
doi: 10.1002/elps.201800328
doi:

Substances chimiques

Actins 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-253

Subventions

Organisme : National Health and Medical Research Council
Pays : International

Informations de copyright

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Georgia M Parkin (GM)

The Molecular Psychiatry Laboratory, the Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia.
The Cooperative Research Centre for Mental Health, Parkville, Victoria, Australia.

Madhara Udawela (M)

The Molecular Psychiatry Laboratory, the Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia.
The Cooperative Research Centre for Mental Health, Parkville, Victoria, Australia.

Andrew Gibbons (A)

The Molecular Psychiatry Laboratory, the Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia.

Brian Dean (B)

The Molecular Psychiatry Laboratory, the Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia.
The Cooperative Research Centre for Mental Health, Parkville, Victoria, Australia.
Centre for Mental Health, the Faculty of Health, Arts and Design, Swinburne University, Hawthorn, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH